Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
However, conclusive evidence supporting these claims remains limited, and more extensive research is needed to substantiate these purported benefits comprehensively
[DOI] [PubMed] [Google Scholar] 12.Liou G.G., Hsieh C.C., Lee Y.J., Li P.H., Tsai M.S., Li C.T., Wang S.H
6 patients have shared ratings for Any Lab Test Now in Houston on Solv
Journal of clinical medicine, 14(5), 1478
Allergy Information This product contains no gluten, dairy, or artificial preservatives, but it is advisable to read the label for any potential allergens